|
|
1 |
MELDOZ |
ALENDRONIC ACID (as alendronate sodium)
M05BA04 |
TABLET, 70MG/TAB |
BT x 4 (1 blister x 4) |
DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
INSTRUCTIONS |
1 |
|
|
3 |
SATURNIL |
ALPRAZOLAM
N05BA12 |
TABLET, 0.5MG/TAB |
BT x 30 (3 blisters x 10) |
ANXIOLYTICS |
INSTRUCTIONS |
1 |
|
|
4 |
MINITRAN |
AMITRIPTYLINE HCl + PERPHENAZINE
N06CA01 |
TABLET, (10 +2)MG/TAB |
BT x 50 (5 blisters x 10) |
PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION |
INSTRUCTIONS |
1 |
|
|
5 |
MINITRAN |
AMITRIPTYLINE HCl + PERPHENAZINE
N06CA01 |
TABLET, (10 +4)MG/TAB |
BT x 50 (5 blisters x 10) |
PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION |
INSTRUCTIONS |
1 |
|
|
6 |
MINITRAN |
AMITRIPTYLINE HCl + PERPHENAZINE
N06CA01 |
TABLET, (25 +2)MG/TAB |
BT x 50 (5 blisters x 10) |
PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION |
INSTRUCTIONS |
1 |
|
|
7 |
MINITRAN |
AMITRIPTYLINE HCl + PERPHENAZINE
N06CA01 |
TABLET, (25+4)MG/TAB |
BT x 50 (5 blisters x 10) |
PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION |
INSTRUCTIONS |
1 |
|
|
8 |
CARDIOSTYL |
ATORVASTATIN (as Atorvastatin Calcium Trihydrate
C10AA05 |
F.C.TAB, 20MG/TAB |
BT x 28 (4 blisters x 7) |
LIPID MODIFYING AGENTS, PLAIN |
INSTRUCTIONS |
1 |
|
|
9 |
CARDIOSTYL |
ATORVASTATIN (as Atorvastatin Calcium Trihydrate)
C10AA05 |
F.C.TAB, 40MG/TAB |
BT x 28 (4 blisters x 7) |
LIPID MODIFYING AGENTS, PLAIN |
INSTRUCTIONS |
1 |
|
|
10 |
KLOREF |
BETAINE HCL + POTASSIUM BICARBONATE
A12BA30 |
EFFERVESCENT TABLET, (1035+675)MG/TAB |
BT x 30 (Plastic vial) |
HYPOKALEMIA |
INSTRUCTIONS |
1 |
|
|
11 |
NOTORIUM |
BROMAZEPAM
N05BA08 |
TABLET, 1.5MG/TAB |
BT x 30 (3 blisters x 10) |
ANXIOLYTICS |
INSTRUCTIONS |
1 |
|
|
12 |
NOTORIUM |
BROMAZEPAM
N05BA08 |
TABLET, 3MG/TAB |
BT x 30 (3 blisters x 10) |
ANXIOLYTICS |
INSTRUCTIONS |
1 |
|
|
13 |
NOTORIUM |
BROMAZEPAM
N05BA08 |
TABLET, 6MG/TAB |
BT x 30 (3 blisters x 10) |
ANXIOLYTICS |
INSTRUCTIONS |
1 |
|
|
14 |
NORMOLOSE |
CAPTOPRIL
C09AA01 |
TABLET, 50MG/TAB |
BT x 20 (2 blisters x 10) |
ACE INHIBITORS, PLAIN |
INSTRUCTIONS |
1 |
|
|
15 |
NORMOLOSE-H |
CAPTOPRIL + HYDROCHLOROTHIAZIDE
C09BA01 |
TABLET, (50+25)MG/TAB |
BT x 20 (2 blisters x 10) |
ACE INHIBITORS, COMBINATIONS |
INSTRUCTIONS |
1 |
|
|
16 |
CEFACLORIL |
CEFACLOR (as Cefaclor Monohydrate)
J01DC04 |
CAPSULE, 500MG/CAP |
BT x12 (3 blisters x 4) |
ANTIBACTERIALS FOR SYSTEMIC USE, OTHER BETA-LACTAM ANTIBACTERIALS |
INSTRUCTIONS |
1 |
|
|
17 |
CEFACLORIL |
CEFACLOR (as Cefaclor Monohydrate)
J01DC04 |
GRA.OR.SUS, 500MG/5ML |
BT x FL x 60 ml |
ANTIBACTERIALS FOR SYSTEMIC USE, OTHER BETA-LACTAM ANTIBACTERIALS |
INSTRUCTIONS |
1 |
|
|
18 |
CEFATRIZINE/ADELCO |
CEFATRIZINE PROPYLENE GLYCOLATE
J01DB07 |
CAPSULE, 500MG/CAP |
CAPS: BT x12 (1 blister x 12) |
ANTIBACTERIALS FOR SYSTEMIC USE, OTHER BETA-LACTAM ANTIBACTERIALS |
|
1 |
|
|
19 |
CEFATRIZINE/ADELCO |
CEFATRIZINE PROPYLENE GLYCOLATE
J01DB07 |
ORAL SUSPENS., 500MG/5ML |
PD.ORA.SUS: BT x FL x 60 ml |
ANTIBACTERIALS FOR SYSTEMIC USE, OTHER BETA-LACTAM ANTIBACTERIALS |
|
1 |
|
|
20 |
ISTAMEX |
CHLORPHENAMINE MALEATE
R06AB04 |
TABLET, 4MG/TAB |
BT x 20 (2 blisters x 10) |
ANTIHISTAMINES FOR SYSTEMIC USE |
INSTRUCTIONS |
1 |
|
|
21 |
ISTAMEX |
CHLORPHENAMINE MALEATE
R06AB04 |
SYRUP, 2MG/5ML |
BT x FL x 100 ml |
ANTIHISTAMINES FOR SYSTEMIC USE |
INSTRUCTIONS |
1 |
